SunTrust Banks Raises LHC Group (LHCG) Price Target to $115.00

LHC Group (NASDAQ:LHCG) had its price target raised by equities research analysts at SunTrust Banks to $115.00 in a note issued to investors on Thursday, The Fly reports. The brokerage currently has a “buy” rating on the health services provider’s stock. SunTrust Banks’ price target suggests a potential upside of 19.05% from the company’s current price.

Other equities analysts also recently issued research reports about the stock. Jefferies Financial Group boosted their target price on shares of LHC Group to $120.00 and gave the stock a “buy” rating in a report on Friday, August 3rd. BidaskClub downgraded shares of LHC Group from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 10th. Benchmark set a $110.00 target price on shares of LHC Group and gave the stock a “buy” rating in a report on Thursday, August 2nd. ValuEngine upgraded shares of LHC Group from a “hold” rating to a “buy” rating in a research report on Saturday, June 2nd. Finally, Zacks Investment Research upgraded shares of LHC Group from a “hold” rating to a “buy” rating and set a $96.00 price target on the stock in a research report on Thursday, June 21st. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $100.20.

LHCG stock opened at $96.60 on Thursday. LHC Group has a one year low of $58.65 and a one year high of $100.90. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.18. The firm has a market capitalization of $2.98 billion, a PE ratio of 39.92, a P/E/G ratio of 1.49 and a beta of 0.52.

LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, August 1st. The health services provider reported $0.84 EPS for the quarter, topping the consensus estimate of $0.78 by $0.06. LHC Group had a net margin of 3.75% and a return on equity of 8.33%. The firm had revenue of $502.00 million for the quarter, compared to the consensus estimate of $509.03 million. During the same quarter in the previous year, the firm earned $0.63 earnings per share. The company’s quarterly revenue was up 95.0% compared to the same quarter last year. equities research analysts predict that LHC Group will post 3.52 EPS for the current year.

In other LHC Group news, SVP Jeff Reibel sold 1,921 shares of the business’s stock in a transaction on Monday, August 20th. The shares were sold at an average price of $94.12, for a total transaction of $180,804.52. Following the transaction, the senior vice president now owns 8,125 shares in the company, valued at $764,725. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Donald Dwayne Stelly sold 2,756 shares of the business’s stock in a transaction on Friday, September 7th. The shares were sold at an average price of $99.32, for a total transaction of $273,725.92. Following the transaction, the chief operating officer now owns 104,512 shares in the company, valued at approximately $10,380,131.84. The disclosure for this sale can be found here. Insiders own 6.80% of the company’s stock.

A number of hedge funds have recently bought and sold shares of LHCG. SG Americas Securities LLC bought a new position in LHC Group during the first quarter valued at $105,000. Envestnet Asset Management Inc. bought a new position in LHC Group during the first quarter valued at $134,000. Cubist Systematic Strategies LLC increased its position in LHC Group by 36.9% during the first quarter. Cubist Systematic Strategies LLC now owns 2,636 shares of the health services provider’s stock valued at $162,000 after acquiring an additional 711 shares during the last quarter. Bank of Montreal Can increased its position in LHC Group by 251.9% during the second quarter. Bank of Montreal Can now owns 2,481 shares of the health services provider’s stock valued at $212,000 after acquiring an additional 1,776 shares during the last quarter. Finally, M&T Bank Corp bought a new position in LHC Group during the first quarter valued at $228,000. Institutional investors and hedge funds own 87.05% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Recommended Story: Short Selling – Explanation For Shorting Stocks

The Fly

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply